Speaker |
Title |
File name |
Bjorn Wettermark |
Data sources for DU including quality and validity |
Wed intro |
Irene Eriksson |
Record linkage in drug utilisation studies |
W1A Eriksson |
Tatiana Luz |
Data sources overview |
W1A Luz |
Maria Rikala |
Validity of register data |
W1A Rikala |
Morten Andersen |
Measuring drug use in dynamic cohorts |
W1B Andersen |
Helga Gardarsdottir |
Longitudinal databases |
W1B Gardarsdottir |
Eric VanGanse |
Use of therapies and outcomes |
W1B VanGanse |
Hanne Strom |
Classification systems & measurement units of drug utilization |
W2A ATC_2014 |
Solveig Sakshaug |
Application of ATC/DDD in health policy and drug utilisation |
W2A Application ATC/DDD |
Monique Elseviers |
Measuring patient adherence |
W2B Elseviers |
Bernard Vrijens |
Electronic monitoring of patient adherence |
W2B Vrijens |
Jaco Voorham |
Database research on patient adherence |
W2B Voorham |
Petra Denig |
Types of prescribing quality indicators (PQI) |
W3A PQI Denig |
Anke Lambooij |
Prescribing quality indicators (PQI) in practice |
W3A PQI Lambooij |
Grigory Sidorenkov |
Development and validation of prescribing quality indicators (PQI) |
W3A PQI Sidorenkov |
Juan Merlo |
Introduction to multilevel analysis |
W3B Merlo |
Doug Steinke |
Interrupted time series analysis |
W3B Steinke |
Maria Matuz and Ria Benko |
Introduction to visualisation |
W4A Matuz Benko |
Mikael Hoffmann |
Time and geospatial visualisation |
W4A Hoffmann |
Judith de Jong |
Explaining medical practice variations |
W4B De Jong |
Brian Godman |
Policies and cross-national variability |
W4B Godman |
Fanny Janssen |
Modelling population level drug use |
W4B Janssen |